Objective
12% of adults suffer from obstructive sleep apnea (OSA). Despite the fact that it is a serious disease, it goes undiagnosed 80% of the time. The cost of undiagnosed OSA patients is €6,000 per person per year whilst the cost of diagnosed patients is only €2,000 per person per year. Multiplying by around €4,000 that could be saved per diagnosed person, the total savings would be €160 billion/year.
Very effective treatment options exist, but the traditional diagnostic infrastructure is neither affordable nor scalable to diagnose this vast number of unidentified sufferers. To this day, the polysomnography is the gold-standard for diagnosing OSA. However, this method is expensive, time-consuming and cannot keep pace with the huge demand.
Neoma Labs has developed Sensa: a cost-effective, miniaturized and connected device that has the potential to become the new gold-standard in OSA diagnostic. The unique approach is measuring mandibular movements to assess OSA. The Sensa solution adds a qualitative layer to the quantitative measures, providing consumers with a sense of control over their health-life balance.
The OSA diagnostics market is driven by a growing awareness regarding the ill effects of untreated sleep apnea, a large pool of undiagnosed OSA patients as well as emerging technologies. Regarding our revenue model, we are considering a pay-per-use model at €50/screening.
With its simplicity and high clinical validation, Sensa will be able to help lower the 80% of OSA patients who go undiagnosed, thereby reducing the costs/burden associated with the disease. With around 408 million adults in the EU, this would mean 49 million people suffer from sleep apnea and 40 million never get diagnosed.
Neoma Labs was founded in June 2015 by a team of experts with professional experience in the field of cardio-respiratory and sleep medicine (with previous experiences in Belgian and American companies, both specialized in the field of cardio-respiratory medical instrumentations.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine psychiatry sleep disorders
- medical and health sciences health sciences public health
- social sciences economics and business economics production economics productivity
- engineering and technology electrical engineering, electronic engineering, information engineering electronic engineering sensors
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.3. - PRIORITY 'Societal challenges
See all projects funded under this programme -
H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-EIC-SMEInst-2018-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
5101 Namur
Belgium
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.